|
The Cancer Drugs Fund (CDF) was introduced in England in 2011. It was established in order to provide a means by which National Health Service (NHS) patients in England could get cancer drugs that are not routinely available on the NHS. Its establishment was confirmed by the UK government's coalition agreement in 2010,〔The Coalition: our programme for government (), 2010〕 and by the White Paper, Equity and excellence – Liberating the NHS.〔Department of Health ("Equity and excellence – Liberating the NHS" ), 2010〕 == Objectives == The objectives of the CDF, as set out by the UK government,〔Department of Health ("The Cancer Drugs Fund: Guidance to support operation of the Cancer Drugs Fund in 2012-13", 2012 )〕 are that it should: * provide maximum support to NHS patients * put clinicians and cancer specialists at the heart of decision-making, consistent with the Government’s wider policy of empowering health professionals and enabling them to use their professional judgement about what is right for patients * act as an effective bridge to the Government’s aim of introducing a value-based pricing system for branded drugs in 2014. 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Cancer Drugs Fund」の詳細全文を読む スポンサード リンク
|